跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AVTOZMA tocilizumab (rch) 400 mg/20 mL injection concentrated vial - TGA Drug Approval Details
Approvals
/
TGA
/
AVTOZMA tocilizumab (rch) 400 mg/20 mL injection concentrated vial
Approved
STANDARD
AVTOZMA tocilizumab (rch) 400 mg/20 mL injection concentrated vial
Celltrion Healthcare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
df2d3ea86bac6bdc
Company
Celltrion Healthcare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
df2d3ea86bac6bdc
Product Name
AVTOZMA tocilizumab (rch) 400 mg/20 mL injection concentrated vial
Artg Id
444943
Artg Name
AVTOZMA tocilizumab (rch) 400 mg/20 mL injection concentrated vial
Sponsor
Celltrion Healthcare Australia Pty Ltd
Company Detail Path
/organization/celltrion-healthcare-australia-pty-ltd
Artg Date
2025-05-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
REPI
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
df2d3ea86bac6bdc
Type
Standard
Back to TGA Approvals
